Visceral Involvements and Long-term Sequelae in Drug-induced Hypersensitivity Syndrome
Section snippets
Diagnosis and clinical course of DIHS/DRESS
DIHS/DRESS appears after a 2-week to 3-month exposure to a limited number of drugs, including anticonvulsants, dapsone, allopurinol, and minocycline.10 The delayed onset in relation to the introduction of the causative drug is 1 of the more important features of DIHS/DRESS. This feature can be used to distinguish DIHS/DRESS from other types of drug eruptions, which typically begin 1 to 2 weeks after initiating therapy.
The criteria for the diagnosis of DRESS proposed by Bocquet and colleagues3
Visceral organ failures observed during the course of DIHS/DRESS
A variety of visceral involvements are observed at various time points after onset despite withdrawal of the causative drug. Box 1 lists visceral involvements that appear from the onset of the symptoms to clinical resolution of the disease. Some of them are strongly related to herpesvirus reactivation.
Long-term sequelae observed after symptom-free interval in DIHS
Several articles, including the authors', have shown the occurrence of autoimmune diseases and/or production of autoantibodies after resolution of DIHS/DRESS (Box 2). These autoimmune diseases include type 1 diabetes mellitus (DM),51, 52, 53, 54, 55, 56 autoimmune thyroid disease,38, 56 sclerodermoid GVHD-like lesions,57 and lupus erythematosus58, 59 (Fig. 4). Some of these autoimmune diseases are similar to those seen after bone marrow transplantation. According to the reports, autoimmune
Summary
DIHS/DRESS is a severe drug-induced systemic reaction with several herpesvirus reactivations. Multiple visceral organ failure such as hepatitis, nephritis, myocarditis, and pneumonitis can appear during the course of disease. The severity of DIHS/DRESS is most frequently determined by the presence of visceral involvement and mortality is related to the degree of systemic involvement. On the other hand, autoimmune diseases such as thyroid disease, sclerodermoid lesions, and lupus erythematosus
References (66)
- et al.
Familial occurrence of hypersensitivity to phenytoin
Am J Med
(1991) - et al.
The variable clinical picture of drug-induced hypersensitivity syndrome (DIHS)/drug rash with eosinophilia and systemic symptoms (DRESS) in relation to the eliciting drug
Immunol Allergy Clin North Am
(2009) Clinical heterogeneity of drug hypersensitivity
Toxicology
(2005)- et al.
Drug-induced hypersensitivity syndrome (DIHS): a reaction induced by a complex interplay among herpesviruses and antiviral and antidrug immune responses
Allergol Int
(2006) - et al.
Fulminant liver failure after vancomycin in a sulfasalazine-induced DRESS syndrome: fatal recurrence after liver transplantation
Am J Transplant
(2009) - et al.
Association between presence of HLA-B*5701, HLA-DR7, and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavir
Lancet
(2002) - et al.
Fulmimant type 1 diabetes mellitus caused by drug hypersensitivity syndrome with human herpesvirus 6
J Am Acad Dermatol
(2006) - et al.
Viral connection between drug rashes and autoimmune diseases: how autoimmune responses are generated after resolution of drug rashes
Autoimmun Rev
(2009) - et al.
Does drug-induced hypersensitivity syndrome elicit bullous pemphigoid?
Allergol Int
(2008) - et al.
The drug hypersensitivity syndrome: what is the pathogenesis?
Arch Dermatol
(2001)
Drug-induced pseudolymphoma and drug hypersensitivity syndrome (drug rash with eosinophilia and systemic symptoms: DRESS)
Semin Cutan Med Surg
Human herpesvirus 6 infection associated with anticonvulsant hypersensitivity syndrome and reactive haemophagocytic syndrome
Br J Dermatol
Human herpesvirus 6 infection as a risk factor of the development of severe drug-induced hypersensitivity
Arch Dermatol
Severe hypersensitivity syndrome due to sulfasalazine associated with reactivation of human herpesvirus 6
Arch Dermatol
Human herpesvirus 6 and drug allergy
Curr Opin Allergy Clin Immunol
The diagnosis of a DRESS syndrome has been sufficiently established on the basis of typical clinical features and viral reactivations
Br J Dermatol
Treatment of severe drug reactions: Stevens-Johnson syndrome, toxic epidermal necrolysis and hypersensitivity syndrome
Dermatol online J
Complex interaction between drug allergy and viral infection
Clin Rev Allergy Immunol
Several herpesviruses can reactivate in a severe drug-induced multiorgan reaction in the same sequential order as in graft-versus-host disease
Br J Dermatol
Association between anticonvulsant hypersensitivity syndrome and human herpesvirus 6 reactivation and hypogammaglobulinemia
Arch Dermatol
Drug-induced hypersensitivity syndrome in pediatric patients
Pediatrics
Drug-induced pseudolymphoma and hypersensitivity syndrome. Two different clinical entities
Arch Dermatol
Cutaneous pseudo-T cell lymphomas. A clinicopathologic study of 20 patients
Cancer
Utility of the lymphocyte transformation test in the diagnosis of drug sensitivity: dependence on its timing and type of drug eruption
Allergy
Sulfasalazine-induced hypersensitivity syndrome and haemophagocytic syndrome associated with reactivation of Epstein-Barr virus
Clin Rheumatol
Drug-induced hypersensitivity syndrome and viral reactivation
T cell involvement in cutaneous drug eruptions
Clin Exp Allergy
Retrospective analysis of 32 pediatric patients with anticonvulsant hypersensitivity syndrome (ACHSS)
Pediatr Dermatol
Dapsone induced cholangitis as a part of dapsone syndrome: a case report
BMC Gastroenterol
Association of human herpesvirus 6 reactivation with the flaring and severity of drug-induced hypersensitivity syndrome
Br J Dermatol
Twelve-year analysis of severe cases of drug reaction with eosinophilia and systemic symptoms
Arch Dermatol
Favourable issue of a fulminant hepatitis associated with sulfasalazine DRESS syndrome without liver transplantation
Intensive Care Med
Severe adverse cutaneous reactions to drugs
N Engl J Med
Cited by (108)
Adult respiratory distress syndrome (ARDS) due to omeprazole-induced drug reaction with eosinophilia and systemic symptoms (DRESS): case report and review of the literature
2024, Revista Espanola de Anestesiologia y ReanimacionPenicillin Allergy: Mechanisms, Diagnosis, and Management
2023, Primary Care - Clinics in Office PracticeDRESS syndrome: A literature review and treatment algorithm
2023, World Allergy Organization JournalA fatal presentation of DRESS syndrome with multiple visceral failure mimicking septic shock
2022, Annals of Medicine and SurgeryUndiagnosed and Rare Diseases in Critical Care: Severe Mucocutaneous Medication Reactions
2022, Critical Care Clinics
This work was supported by Health and Labor Sciences Research Grants from the Ministry of Health, Labor and Welfare of Japan (to Japanese Research Committee on Severe Cutaneous Adverse Reaction [J-SCAR]).